The Relationship between Changes in Weight Status and Insulin Resistance in Youth by Ondrak, Kristin et al.
Hindawi Publishing Corporation
International Journal of Pediatric Endocrinology
Volume 2009, Article ID 862061, 7 pages
doi:10.1155/2009/862061
Research Article
The Relationship between Changes in Weight Status and
Insulin Resistance in Youth
Kristin S. Ondrak,1 Robert G. McMurray,1 Claudio L. Battaglini,1
Kelly R. Evenson,2 and Joanne S. Harrell3
1 Department of Exercise and Sport Science, University of North Carolina at Chapel Hill, 209 Fetzer Gym CB# 8700,
Chapel Hill, NC 27599, USA
2 Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
3 School of Nursing, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
Correspondence should be addressed to Kristin S. Ondrak, kondrak@unc.edu
Received 24 November 2008; Revised 25 February 2009; Accepted 6 April 2009
Recommended by Stephen O’Riordan
This study examined changes in insulin resistance (IR) in 120 youth over two years. IR was quantified via homeostatic model
(HOMA-IR), and weight status changes were quantified via body mass index (BMI). When all participants were considered, the
mean HOMA-IR and BMI increased 13.4% and 1.65 units, respectively. Change in BMI z-score and percent change in HOMA-
IR were moderately associated (r = 0.39). Follow-up analyses were performed for the following weight groups: NN (normal at
baseline and two years later), NO (normal to overweight), ON (overweight to normal), and OO (overweight at both points).
The NO group had a greater change in HOMA-IR (+50%) compared to other groups: ON (−8%), NN (+2%), and OO (−0.1%)
(P < .05). The association between changes in BMI z-score and HOMA-IR was r = 0.49 when only the NO and ON groups were
included. These results reinforce the importance of preventing youth from becoming overweight to control IR.
Copyright © 2009 Kristin S. Ondrak et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. Introduction
Insulin resistance (IR) is a precursor to type II diabetes, and
recent reports show that 52% to 72% of overweight and obese
youth have IR [1, 2]. While numerous cross-sectional studies
have noted positive associations (r = 0.31 to 0.85) between
insulin and measures of adiposity in youth, the relationships
between change in weight status and change in IR have
not been examined thoroughly [2–8]. The few longitudinal
studies of youth have consistently reported that change in
weight is positively associated with change in insulin or
IR and negatively associated with insulin sensitivity [9–
11]. However, these studies have induced weight loss by an
intervention and have not examined what occurs in response
to natural changes in weight status.
The current investigation will add to our understanding
of the relationship between changes in weight status and IR
by directly comparing changes in IR in youth who increased,
decreased, or maintained their weight status over a two-year
period. Analyses were first conducted with all participants in
one group. Secondary analyses were conducted to compare
IR among four weight groups, as described in the Methods
section. We hypothesized that a larger increase in IR would
occur in the participants who were normal weight and
became overweight compared to those who remained normal
weight. Also, we expected that a larger decline in IR would
occur in participants who were overweight and became
normal weight compared to those who remained overweight
two years later.
2. Methods
2.1. Participants. The participants were enrolled in the
Cardiovascular Health in Children III (CHIC) study, Cohort
5 (J.S. Harrell, P.I.). The CHIC III study was a longitudinal
investigation assessing risk factors for cardiovascular disease
in youth from rural North Carolina, taking place from 2000
to 2003. Of the 1566 participants in Cohort 5, the mean ages
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at baseline and followup were 9.6 ± 1.1 years and 11.5 ± 1.0
years, respectively. The sex and racial composition of this
cohort was 50% female, 50% male, 53% Black, 36% White,
and 11% Other races. A total of 120 children and adolescents
were selected from the 1566 participants to participate in this
study, based on their weight status as described in the Group
Analyses section. The age of participants in this investigation
was similar to the original cohort (mean ages 9.8±1.0 years at
baseline and 11.6±1.0 years at followup). There were slightly
more males (62%), and White participants (56%), compared
to the original cohort.
2.2. Procedures. All data were collected at baseline and two
years later, termed baseline and followup in this study. Prior
to data collection, the participants and their parents signed
assent and consent forms, respectively, and all procedures
were reviewed and approved by the Institutional Review
Board at the University of North Carolina at Chapel Hill.
Data were collected at the participants’ schools by trained
research assistants. Height was measured using a stadiometer
(Perspective Enterprises, Portage, MI), and body mass was
assessed via electronic scale (Model 2101KL, Healthometer
Medical, Bridgewater, IL). BMI was calculated from these
measurements (kg/m2). Fat mass and fat free mass were
estimated from measures of percent body fat, obtained
from sum of skinfolds taken at the subscapular and triceps
sites. These measures were taken in triplicate using Lange
calipers (Cambridge Scientific, Cambridge, MD), according
to the guidelines set forth by NHANES III [12]. Equations
specific to each sex, race, and pubertal status were then
applied to estimate percent body fat [13]. In order to
ensure strong intra- and interrater reliability, respectively,
all research assistants were trained by the same investigator,
and height, body mass, and skinfolds were measured by
more than one research assistant for every tenth participant.
If the measurement for any variable was greater than pre-
established quality control criteria, the research assistant was
not permitted to participate in future measurements for that
variable.
Researchers have noted that pubertal status [5, 7, 14,
15] and aerobic fitness [16] influence HOMA-IR; thus,
both measures were included in this investigation. Pubertal
development was quantified using self-report questionnaires
[17]. Aerobic fitness was assessed using a multistage sub-
maximal cycle ergometer test, the Physical Work Capacity
195 or PWC195 [18]. The workload corresponding to a
heart rate of 150–170 bpm was used to predict the maximal
volume of oxygen uptake (pVO2max), and strong corre-
lations (r = 0.81) have been shown between this test
and measured VO2max in children [18]. The results of
the test were expressed in mL of oxygen per kg fat-free
mass per minute (VO2/kgFFM), to eliminate the eﬀect of fat
mass.
Blood was drawn using standard venipuncture methods,
between 7 and 9 am, following an 8-hour fast. The samples
were centrifuged, and the plasma was stored in vials and
frozen in a −80◦C freezer for later analysis. Insulin was
measured from the stored plasma using radioimmunoassay
procedures (Linco, St. Charles, MO), while glucose was ana-
lyzed via automated hexokinase oxidase procedures. These
values were used to calculate IR using the homeostatic model
assessment equation (HOMA-IR); (fasting insulin (μU/mL)
multiplied by fasting glucose concentration (mmol/L))/22.5
[19]. Several recent investigations have shown that HOMA is
both reliable and valid for use in pediatric populations [20–
22].
2.3. Statistical Analysis. Initially, the statistical analyses were
performed with all participants combined into one group
(n = 120). The percent change in HOMA-IR ((follow-up −
baseline)/baseline) was calculated for each participant. Like-
wise, change in weight status was analyzed by calculating
the z-score of BMI change (follow-up BMI z-score minus
baseline BMI z-score). The relationship between percent
change in IR and change in BMI z-score was examined using
Pearson correlations. This association was then examined
after controlling for change in pubertal status and aerobic
fitness, expressed in mL/kgFFM/min (VO2/kgFFM).
To establish which variable had the greatest influence
on HOMA-IR, we repeated these correlation analyses using
percent changes in insulin and glucose as the dependent
variables. The alpha level was set at P < .05, and 95%
confidence intervals were computed for the correlations.
All statistical analyses were conducted using SAS Statistical
Software, Version 9.1 (Cary, NC).
2.4. Group Analyses of Weight Status Change. For the group
analyses of weight status change, participants were divided
into four groups (NO, NN, ON, OO) based upon their
BMI percentile at baseline and followup. BMI percentile was
derived from the Centers for Disease Control and Prevention
(CDC) growth charts from the year 2000 [23]. Normal
weight was defined as >5th and <85th BMI percentile for
age and sex, while overweight was defined as ≥85th BMI
percentile for age and sex. The NO group was comprised of
participants (n = 35) who were normal weight at baseline
and overweight at followup. These individuals were selected
from participants in the original cohort who met these
criteria (n = 60) and had complete data (35 out of 60). A
comparison group, NN, was comprised of 35 participants
who were normal weight at both time points. This group was
randomly selected from participants from the original cohort
who matched those in the NO group by sex, race (Black,
White, or Other), and pubertal status at baseline. Conversely,
the ON group was comprised of 25 participants who were
overweight at baseline and normal weight at followup and
had complete data available (25 out of 35 total). Participants
for the corresponding comparison group, OO, (n = 25) were
randomly selected from eligible participants who matched
those in the ON groups by sex, race, and pubertal status at
baseline.
A one-way ANOVA was computed to compare the
following variables between the four weight groups at
baseline: age, pubertal stage, body mass, height, BMI, BMI
percentile, VO2/kgFFM, glucose, insulin, and HOMA-IR. A
Mantel-Haenszel chi-square was calculated to assess group
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diﬀerences at baseline for the categorical variables race
and sex. To assess group diﬀerences in percent change in
HOMA-IR and BMI change z-score, one-way ANOVAs were
computed. Finally, the association between percent change
in IR and change in BMI z-score was examined for the
two groups that altered their weight status (NO and ON),
using Pearson correlations. Partial correlations between these
variables were calculated after controlling for changes in
pubertal status and VO2/kgFFM. These correlations were
repeated using percent change in insulin and glucose,
respectively, in place of percent change in HOMA-IR to
determine which variable was driving the change in HOMA-
IR.
3. Results
3.1. All Participants. Descriptive characteristics of all par-
ticipants are presented in Table 1. With the exception of
a fairly high BMI, none of the other characteristics were
remarkable. The Pearson correlation between BMI change z-
score and percent change in HOMA-IR was 0.39, P < .05.
After controlling for changes in pubertal status and aerobic
fitness (VO2/kgFFM), the partial correlation increased slightly
to 0.40; P < .05 (Table 2).
The correlations between percent change in glucose
and BMI change z-score were not significant when all
participants were included (P = .14); therefore no further
analyses were conducted using glucose. However, the Pearson
correlations and partial correlations for BMI change z-score
and percent change in insulin were significant and nearly
identical to those for percent change in HOMA-IR (Table 2).
3.2. Weight Group Analysis. Descriptive characteristics of
the four weight groups are presented in Table 3. When
comparing the four groups, there were no diﬀerences for sex
but there were significant diﬀerences for race, such that the
OO and ON groups had fewer Black participants than the
NN and NO groups (χ2: P < .05). Despite similar medians
and ranges of pubertal stages in all four groups (P > .05),
participants in the NO were approximately one year younger
than participants in the other groups (P < .05). There were
no group diﬀerences in glucose at baseline but the OO group
had larger mean values for insulin and HOMA-IR, compared
to all other groups (P < .05).
Over the two-year study period, the NO group had a
greater percent change in HOMA-IR (+50%) than all other
groups, as shown in Table 3 (P < .05). The NN group
had a small increase in HOMA, and the ON group had a
slight decrease, while the OO group changed very little over
the two-year study period. Group diﬀerences for percent
change in insulin were identical to those for percent change
in HOMA-IR (Table 3). When analyzing percent change in
glucose, there were significant diﬀerences (P < .05) between
the NN versus ON and OO groups (Table 3). The ON group
was the only one to show a reduction in glucose.
The correlation between BMI change z-score and percent
change in HOMA-IR was 0.49 (P < .05) when only the NO
and ON groups were analyzed (Table 2). This relationship
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Figure 1: Scatterplot of the relationship between percent change in
HOMA-IR and BMI change z-score, depicted by weight group.
can be seen by comparing these groups in the scatterplot in
Figure 1. Controlling for changes in VO2/kgFFM and pubertal
status did not alter the relationship significantly, as the
correlation was 0.50 (Table 2). Repeating the correlations
for the NO and ON groups with insulin and glucose in
place of HOMA-IR revealed associations of 0.31 and 0.49,
respectively.
4. Discussion
This investigation is one of the first to explore the rela-
tionship between natural progressions in weight status and
changes in HOMA-IR over a two-year period in youth.
Changes in weight status were not artificially manipulated
by an intervention; some children started normal weight
and became overweight, while some who were overweight
became normal weight. When analyzing all participants as
one group, there was a significant correlation (r = 0.39)
between BMI change z-score and percent change in HOMA-
IR even after accounting for any change in pubertal status
or aerobic fitness (r = 0.40). This suggests that changes
in pubertal status and aerobic fitness did not influence
the positive relationship between changes in BMI z-score
and HOMA-IR. Similar associations were found in an
investigation of 9-10-year-old girls followed up ten years
later [24]. In that investigation, a correlation of 0.24 was
reported between change in BMI and HOMA-IR and similar
to the current study; these authors did not use a weight
change intervention. Therefore, there appears to be a weak to
moderate, positive relationship between naturally occurring
alterations in weight status and IR in youth.
4.1. Changes in HOMA-IR among the Weight Groups. As
expected, HOMA-IR increased in the NO group and
decreased in the ON group. The change in BMI z-score
over the two-year period was remarkably similar in these
groups, as it increased by 0.55 in the NO group and decreased
by 0.60 in the ON group. Despite these similarities, the
7.7% reduction in HOMA-IR in the ON group was smaller
than expected; this may be attributed to the relatively low
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HOMA-IR in the ON group at baseline. When comparing
participants who became overweight (NO group) to those
who remained normal weight (NN group), the 50% increase
in HOMA-IR in the NO group was much larger than the
2% increase seen in the NN group. This suggests that
becoming overweight is related to substantial increases in
HOMA-IR that are not present when normal weight status
is maintained. Taken together, these findings imply that
changes in HOMA-IR may be most sensitive to natural
increases in weight status, compared to decreases in or
maintenance of weight status. To our knowledge, no previous
investigation has directly compared participants using these
weight status groups.
The lack of diﬀerences in the percent change in HOMA-
IR between the OO and ON groups may be attributable to
several factors. First, the mean HOMA-IR value for the ON
group was 3.3 units at baseline, which was slightly lower
than expected for overweight participants. This relatively
low baseline value limits the capacity for further reduction
in HOMA-IR in response to weight status change. Second,
research has shown that insulin sensitivity declines as youth
mature and pass through puberty [7, 14, 15]. In this
investigation, most participants advanced by at least one
pubertal stage over the two-year period. The ON group had
the highest median pubertal stage at followup, which may
have increased their resistance to insulin and decreased any
weight-related reductions in IR. A third factor that may
explain the similar changes in HOMA-IR between the OO
and ON groups is the magnitude of weight status change
[11, 25, 26]. For example, Reinehr et al. found significant
improvements in insulin sensitivity only when obese children
decreased their BMI standard deviation score by ≥0.5 (or
2.2 BMI kg/m2) over a one-year period [11]. A similar
investigation found that reductions in BMI SD score of ≥0.5
were also needed in order to elicit significant reductions in
HOMA-IR after one year, and the reduction of BMI in that
group was 3.2 kg/m2 [26]. In the current investigation, the
ON group had a mean BMI reduction of 0.9 kg/m2, which
suggests that the weight status reduction may have been too
small in magnitude to influence IR. Finally, the degree of
overweight may influence the amount of change in IR. For
example, Savoye et al. found reductions in HOMA-IR of 1.5
units in a group of obese participants who decreased their
BMI by 1.7 kg/m2 in one year [27]. The starting BMI for
their group was 35.8 kg/m2, however, which is much higher
than the baseline BMI of 21.4 kg/m2 seen in our ON group.
Taken together, these factors may explain why we saw a small
percent decrease in IR in the ON group despite a 0.60-unit
reduction in BMI changes z-score and subsequently, why we
did not observe significant diﬀerences between the OO and
ON groups.
The Pearson correlation between BMI change z-score
and percent change in HOMA-IR in the NO and ON
participants was moderate in strength (r = 0.49). The partial
correlations between these variables were nearly identical
after controlling for changes in pubertal status and VO2 per
kg of fat-free mass, suggesting that they did not influence
these associations. These results disagree with cross-sectional
studies that show positive relationships between pubertal
Table 1: Descriptive statistics (mean ± standard deviation) at
baseline and follow-up two years later, presented for all participants.
Baseline Follow-up
n 120
Sex (females, males) 62, 58
Race (black, white, other) 58, 56, 6
Age (years) 9.8± 1.0 11.6± 1.1
Median pubertal stage (range) 2 (1–4) 3 (1–5)
Body Mass (kg) 40.9± 12.2 51.4± 13.1
Height (cm) 141.3± 8.8 152.8± 9.5
BMI (kg/m2) 20.2± 4.2 21.9± 4.4
Change in BMI (kg/m2) 1.65± 2.49
BMI percentile 75.4± 22.2 76.8± 21.9
VO2/kgFFM 47.4± 11.4 48.9± 11.0
Glucose (mmol/L) 5.1± 0.5 5.1± 0.5
Percent Δ Glucose 0.97± 12.1
Insulin (pmol/L) 102.8± 61.1 102.1± 65.3
Percent Δ Insulin 10.8± 62.3
HOMA-IR 3.4± 2.1 3.3± 2.4
Percent Δ HOMA-IR 13.4± 68.8
status [5] and IR and negative relationships between fitness
and IR in children and adolescents [16]. However, with
regard to pubertal status, the changes in our participants
were generally quite small which may explain their insignifi-
cant role in these relationships. The majority of participants
(55%) increased by one pubertal stage over the two-year
study period, while 28% did not change pubertal stage, 14%
increased by two stages, and only 3 participants advanced
three stages. Also, changes in fitness over the two-year period
were small, ranging from −0.1 to 2.8 ml/kgFFM/min. This
likely explains why we failed to see a relationship between
changes in fitness and IR, despite a previous investigation
that reported a correlation of −0.41 between VO2max in
mL/kgLBM/min and fasting insulin [16].
4.2. HOMA-IR versus Fasting Insulin. In general, the results
of this investigation were nearly identical when either percent
change in HOMA-IR or percent change in insulin was
used as the dependent variable in the correlation analyses
(Table 2). This suggests that insulin was the driving force
behind HOMA-IR, and the influence of glucose was quite
small. This was also evident in the weight group comparisons
at baseline, as there were no group diﬀerences in glucose
but the OO group had significantly higher insulin and
HOMA-IR compared to all other groups. Our findings agree
with previous research showing strong associations between
fasting insulin and HOMA-IR [28]. In fact, the correlation
between HOMA-IR and insulin was 0.98 at baseline and
0.99 at follow-up (P < .05), while the correlation between
HOMA-IR and glucose was 0.51 and 0.24, respectively, (P <
.05). Thus, in our apparently healthy participants, HOMA-
IR did not yield stronger associations than insulin alone, and
this agrees with results from previous research supporting
the use of HOMA-IR [22, 29].
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Table 2: Pearson correlations (95% confidence intervals) between z-score of change in BMI and percent change in HOMA-IR and insulin,
before and after controlling for changes in pubertal status and VO2/kgFFM.
∗
Sample size z-score of Δ BMI
z-score of Δ BMI, controlling for
changes in pubertal status and
VO2/kgFFM
Percent Δ HOMA-IR:
120
0.39 0.40
All participants (0.22 to 0.53) (0.23 to 0.54)
Percent Δ HOMA-IR:
60
0.49 0.50
NO and ON groups (0.26 to 0.66) (0.28 to 0.67)
Percent Δ insulin:
120
0.40 0.42
All participants (0.24 to 0.54) (0.25 to 0.55)
Percent Δ insulin:
60
0.49 0.51
NO and ON groups (0.26 to 0.66) (0.29 to 0.68)
∗All correlations were P < .05.
Table 3: Descriptive statistics (mean ± standard deviation) at baseline and follow-up two years later, presented by weight status group.
NN (n = 35) NO (n = 35) ON (n = 25) OO (n = 25)
Baseline Follow-up Baseline followup Baseline followup Baseline followup
Sex (females, males) 17, 18 17, 18 14, 11 14, 11
Race (black, white, other) 21, 13, 1 21, 13, 1 8, 15, 2 8, 15, 2
Age (years)∗ 9.8± 0.9 11.7± 0.9 9.2± 1.0 11.1± 1.0 10.2± 1.0 12.0± 1.0 10.1± 1.1 12.0± 1.1
Median pubertal stage (range) 2 (1–4) 3 (1–5) 2 (1–4) 3 (1–4) 2 (1–4) 4 (2–4) 2 (1–4) 3 (1–5)
Body mass (kg)† 34.2± 5.3 42.8± 6.5 34.9± 5.6 49.8± 7.6 45.9± 8.8 51.6± 6.3 53.6± 16.1 65.2± 18.9
Height (cm)∗ 141.0± 7.3 152.4± 8.1 137.0± 8.2 148.4± 8.9 145.8± 8.7 158.5± 9.6 143.4± 9.1 153.9± 9.2
BMI (kg/m2)† 17.1± 1.6 18.4± 1.7 18.5± 1.1 22.5± 1.8 21.4± 2.3 20.5± 0.9 25.7± 5.3 27.2± 6.0
BMI change z-score∧∧ −0.07± 0.24 0.55± 0.40 −0.60± 0.55 −0.07± 0.47
BMI percentile‡ 50.8± 24.4 51.8± 23.1 76.0± 8.0 90.2± 3.1 89.2± 2.9 75.3± 9.3 95.3± 3.9 94.4± 4.2
VO2/kgFFM
∧ 51.5± 10.9 53.8± 9.7 47.9± 10.4 47.9± 10.0 45.9± 12.0 47.2± 9.4 42.2± 11.9 43.4± 10.1
Glucose (mmol/L) 4.9± 0.5 5.1± 0.4 5.0± 0.4 5.1± 0.5 5.2± 0.4 5.0± 0.3 5.3± 0.5 5.0± 0.5
Percent Δ Glucose†† 5.1± 12.9 2.4± 11.2 −2.3± 10.0 3.6± 12.3
Insulin (pmol/L)∗∗ 84.0± 71.5 75.0± 56.9 92.4± 49.3 116.0± 78.5 100.0± 31.9 93.8± 53.5 144.5± 67.4 127.8± 55.6
Percent Δ Insulin§ −2.8± 42.8 43.8± 84.8 −7.2± 38.2 1.6± 52.2
HOMA-IR∗∗ 2.7± 2.4 2.5± 2.1 3.0± 1.8 3.9± 3.0 3.3± 1.1 3.0± 1.9 4.9± 2.4 4.1± 1.8
Percent Δ HOMA-IR§ 2.1± 48.5 49.7± 93.5 −7.7± 43.0 −0.8± 55.5
∗P < .05; NO < all other groups at baseline, §P < .05; NO versus NN, ON, and OO, †P < .05; NN and NO < ON < OO at baseline, ‡P < .05; NN < NO < ON
and OO at baseline, ∧P < .05; NN < OO at baseline, ††P < .05; NN versus ON and OO, ∗∗P < .05; NN, NO, and ON < OO at baseline, ∧∧P < .05, ON < NN
and OO < NO.
As with any investigation, there are inherent strengths
and limitations. One of the strengths of this study is the
inclusion of participants who changed their weight status
favorably and unfavorably as well as participants who did
not change weight status. Likewise, this study is one of the
few to describe the natural progression of the HOMA-IR in
youth who underwent favorable changes in weight status by
moving from overweight to normal weight, as the majority of
research focuses on youth who move from normal weight to
overweight status. A final strongpoint of this investigation is
the consideration of pubertal status and aerobic fitness, as it
is likely that they are related to weight status and HOMA-IR
in youth.
Some limitations of this investigation include the rel-
atively small sample sizes in each of the weight groups
and the breadth of BMI values in the overweight category
(≥85th percentile). If more participants were included, the
overweight groups may have been divided further, into
the “at risk for overweight” and “overweight” groups, as
described by the CDC [23]. Another limitation is the use of
self-report measures of pubertal status. While some research
has reported high correlations (r = 0.82) among self- and
physician-generated ratings of Tanner stage in adolescent
girls [30], other studies have weaker relationships [31]. Also,
there were slight inequities for age and race, which may have
impacted HOMA-IR values in this investigation, as research
shows that black females had higher insulin and HOMA-
IR values compared to White girls, regardless of pubertal
stage [24]. Additionally, cut-points ranging from 3.16 to 4.0
for HOMA-IR have been used to classify IR in children and
adolescents, yet there is no universally accepted value for
use in youth [2, 22]. This complicates the interpretation of
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results, as diﬀerent conclusions can be formulated depending
upon which cut-point is used. As a result, we did not
dichotomize individuals as insulin resistant or not. Once
a consensus is reached regarding these cut-points, normal
and overweight participants could be compared using these
insulin resistance classifications. The weight group analysis
could be considered both a strength, as mentioned above, or
a weakness. As a weakness, the groups have limited power,
which could skew our findings. Also, although determined
a priori, the criteria for allocation to a group were artificial.
There is no reason why a person in the normal group cannot
have a large change in BMI; yet because they do not cross the
cut-point, they do not enter the “overweight” group. Thus
our grouping does not allow for any conclusions regarding
a large change in BMI, without a change in categorization.
Finally, we are unable to determine temporality of these
relationships using the current design. As a result, we cannot
determine if changes in weight status caused changes in
HOMA-IR or vice versa and instead can only comment upon
their associations.
5. Conclusion
In youth, changes in BMI z-score and percent change in
HOMA-IR over two years are positively related. Specifically,
participants who underwent natural increases in weight
status and became overweight had substantial increases in
HOMA-IR, and the magnitude of these changes was greater
than those for youth who decreased or maintained their
weight status. These results reinforce the importance of
preventing overweight during childhood.
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